Alfa Corpuscles Private Limited - Due diligence report

A 360° intelligence report on Alfacorpuscles: trust score, financial health, credit view, compliance, directors, growth and distress signals…

2007-05-08 Delhi, Delhi Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Alfacorpuscles — 360° Intelligence Report

Generated from MCA filings & public records
60/100
Trust Score
Moderate

Alfacorpuscles is assessed as Moderate with a Trust Score of 60/100. Alfacorpuscles is an active private limited indian non-government company incorporated in 2007, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 01 Nov 2026 from the latest processed filings. Alfa Corpuscles Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
60/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
51/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.

Charges position: 2 open (1.30 cr) · 1 satisfied (50.00 Lakh).

Banking relationships (from registered charges)
LenderChargesAmount
Technology Development Board1 48.0 cr
The Jammu And Kashmir Bank Limited1 48.0 cr
Biotechnology Industry Research Assistance Council1 48.0 cr
Compliance Score: 51/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2025).
  • Flagged by authority: EPFO.
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ATUL SARDANA 01234567 Director 01/04/2018 6 yrs Approved
MIHIRKUMAR ARVIND JOSHI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2021)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
9 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: ATUL SARDANA (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 70
Growth signals & trust indicators
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
Compliance score is weak (51/100).
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence59/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment37/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 1.30 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view38/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
01 Sep 2022
Charge satisfied
The Jammu And Kashmir Bank Limited
13 May 2019
Director ceased
AKASH MAHENDRA BHAVSAR
27 Oct 2018
Director ceased
APURVA BHUPENDRA SHAH
07 Aug 2018
Director appointed
MIHIRKUMAR ARVIND JOSHI (Nominee Director)
Director ceased
ARVIND MODI
18 Oct 2016
Director ceased
VANDANA SARDANA
21 Jul 2015
Securities allotted
121212.00 Equity Shares - 50.00 Lakh raised
17 Jan 2015
Securities allotted
121212.00 Equity Shares - 50.00 Lakh raised
21 Nov 2014
Charge created
Biotechnology Industry Research Assistance Council - 16.00 Lakh
31 Mar 2014
Securities allotted
121212.00 Equity Shares - 50.00 Lakh raised
09 Dec 2013
Securities allotted
181818.00 Equity Shares - 75.00 Lakh raised
29 Mar 2013
Securities allotted
242420.00 Equity Shares - 100.00 Lakh raised
27 Nov 2012
Securities allotted
36364.00 Equity Shares - 1.50 cr raised
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 9 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Strumed Solutions Private Limited U33119GJ2019PTC120565 Surat, Gujarat, India
Ktm Healthcare Private Limited U24297UP2006PTC031281 Noida, Uttar Pradesh, India
Bioscan Research U74999GJ2017PTC099067 Ahmadabad City, Gujarat, India
Anveera Tech Private Limited U73100PN1997PTC171252 Pune, Maharashtra, India
Yash Conchem Private Limited U24296TN2009PTC072226 Ponneri, Tamil Nadu, India
Rajdhani Chemicals P. Ltd. U24110TG1988PTC008600 Hyderabad, Telangana, India
Polycure Martech Ltd U13112RJ1996PLC011668 Jaipur, Rajasthan, India
Unico Pharma Private Limited U74920UP2014PTC065325 Noida, Uttar Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Alfacorpuscles before audits and certifications: compliance score 51/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Alfacorpuscles: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Alfacorpuscles - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 60/100, distress signals and MSME payment-delay disclosures - know whether Alfacorpuscles pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Alfacorpuscles - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Alfacorpuscles an active company?

Alfacorpuscles has MCA status “Active” with a compliance score of 51/100 (Moderate).

Is Alfacorpuscles financially healthy?

Alfacorpuscles has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Alfacorpuscles?

Its overall Trust Score is 60/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Alfacorpuscles?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Alfacorpuscles have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Alfacorpuscles up to date with its ROC filings?

Balance sheet slightly behind (Mar 2025). Overall compliance score: 51/100 (Moderate).

Is it risky to lend to Alfacorpuscles?

Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.